PF4 and autoimmune polyendocrinopathy: Platelet factor 4, a thrombogenic protein released by activated platelets, can form stable complexes with β2GPI in APS patients, and aβ2GPI antibodies binding to these complexes trigger p38 MAPK phosphorylation and subsequent thromboxane B2 production (23).